abstract |
The invention relates to a method for isolation, purification and industrial scale expansion of human adipose tissue derived mesenchymal stem cells (MSCs). The invention also relates to a method for treating and a therapeutic product for treating type-1 diabetes mellitus, critical limb ischemia, multiple sclerosis, Duchenne muscular dystrophy, rheumatoid arthritis, cerebral stroke, type-II diabetes, idiopathic pulmonary fibrosis, dilated cardiomyopathy, and osteoarthritis comprising MSCs. |